Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Britschgi

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Allergy and Clinical Immunology|April 7, 2007
Cross-reactivity patterns of T cells specific for iodinated contrast mediaMarianne Lerch, Monika Keller, Markus Britschgi, et al.
Molecular & Cellular Proteomics : MCP|July 12, 2011
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteomeMarkus Britschgi, Kaspar Rufibach, Sarah L Bauer Huang, et al.
The American Journal of Pathology|March 21, 2012
Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patientsTomomi Hosono-Fukao, Shiori Ohtake-Niimi, Hitomi Hoshino, et al.
International Journal of Molecular Sciences|July 11, 2020
Large-Scale Production of Human iPSC-Derived Macrophages for Drug ScreeningSimon Gutbier, Florian Wanke, Nadine Dahm, et al.
Frontiers in Immunology|February 22, 2021
Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived MicrogliaMarvin Reich, Iñaki Paris, Martin Ebeling, et al.
Elife|December 10, 2019
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopyRicardo Guerrero-Ferreira, Nicholas Mi Taylor, Ana-Andreea Arteni, et al.
Acta Neuropathologica Communications|June 6, 2022
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathiesTim E Moors, Daniel Mona, Stefan Luehe, et al.
The Journal of Experimental Medicine|January 9, 2013
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survivalJian Luo, Fiona Elwood, Markus Britschgi, et al.
Nature Communications|August 27, 2021
Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson's diseaseJuozas Gordevicius, Peipei Li, Lee L Marshall, et al.
Nature Communications|July 18, 2025
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson's diseaseIrene Frigerio, Martino L Morella, Amber B Winkelaar, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|April 7, 2007
Cross-reactivity patterns of T cells specific for iodinated contrast mediaMarianne Lerch, Monika Keller, Markus Britschgi, et al.
Molecular & Cellular Proteomics : MCP|July 12, 2011
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteomeMarkus Britschgi, Kaspar Rufibach, Sarah L Bauer Huang, et al.
The American Journal of Pathology|March 21, 2012
Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patientsTomomi Hosono-Fukao, Shiori Ohtake-Niimi, Hitomi Hoshino, et al.
International Journal of Molecular Sciences|July 11, 2020
Large-Scale Production of Human iPSC-Derived Macrophages for Drug ScreeningSimon Gutbier, Florian Wanke, Nadine Dahm, et al.
Frontiers in Immunology|February 22, 2021
Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived MicrogliaMarvin Reich, Iñaki Paris, Martin Ebeling, et al.
Elife|December 10, 2019
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopyRicardo Guerrero-Ferreira, Nicholas Mi Taylor, Ana-Andreea Arteni, et al.
Acta Neuropathologica Communications|June 6, 2022
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathiesTim E Moors, Daniel Mona, Stefan Luehe, et al.
The Journal of Experimental Medicine|January 9, 2013
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survivalJian Luo, Fiona Elwood, Markus Britschgi, et al.
Nature Communications|August 27, 2021
Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson's diseaseJuozas Gordevicius, Peipei Li, Lee L Marshall, et al.
Nature Communications|July 18, 2025
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson's diseaseIrene Frigerio, Martino L Morella, Amber B Winkelaar, et al.
Pageof 5